CIBLAGE DE L'ACTIVITÉ CAPN9/CAPNS2 EN TANT QUE STRATÉGIE THÉRAPEUTIQUE POUR LE TRAITEMENT DE LA DIFFÉRENTIATION DES MYOFIBROBLASTES ET DES PATHOLOGIES ASSOCIÉES
Provided herein are, inter alia, compositions and methods for identifying and using agents capable of inhibiting myofibroblast transition as well as methods for treating diseases associated with the same in a subject in need thereof.